Proceedings of the National Academy of Sciences, Volume 123, Issue 13, March 2026. SignificanceAutoimmune neurological syndromes (AINS) with antibodies targeting glutamic acid decarboxylase 65 (anti-GAD65 AINS) show limited response to currently available immunotherapies and are associated with poor clinical outcomes. A better ...
PNAS published a clinical update in Research Highlights on 25 Mar 2026.
The item focuses on Immune cell profiling reveals expanded stem cell–like memory T cells in anti-GAD65-associated neurological syndromes.
Review the original article for the full source wording and details.